Health Trials

Refractoryrelapse Acute Myeloid Leukemia

2

Review clinical trials related to Refractoryrelapse Acute Myeloid Leukemia. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML

A Clinical Study to Investigate the Safety and Efficacy of CT0890B in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

Participants needed: 27
Trial details
Phase: Phase 1Age: 18-70Biological sex: AllType: InterventionalSponsor: Peking University People's HospitalUpdated: Jun 1, 2026Locations: 1
Eligibility criteria

Age 18-70 years (inclusive), male or female. [+8]

Participants were diagnosed with acute promyelocytic leukemia (APL), BCR-ABL pos... [+10]

Read more
Status: Recruiting

Study of C6 Ceramide NanoLiposome (CNL) in Patients With Relapsed/Refractory Acute Myeloid Leukemia

The study objective is to evaluate patient safety for patients with refractory and relapsed AML being treated with Ceramide NanoLiposome (CNL) .

Participants needed: 15
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Keystone Nano, IncUpdated: Mar 31, 2026Locations: 1
Eligibility criteria

Signed informed consent is obtained prior to conducting any study-specific scree... [+9]

Uncontrolled intercurrent illness including, but not limited to, symptomatic con... [+10]

Read more